清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Kinetic Modeling and Parametric Imaging of 13N-NH3 in Treatment-Naïve Lung Cancer

肺癌 动能 癌症 化学 放射化学 物理 医学 病理 内科学 量子力学
作者
Hui Yuan,Fanghu Wang,Chen Yang,Xiaoqiang Pan,Qing Zhang,Tao Sun,Lei Jiang
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:22 (7): 4314-4320
标识
DOI:10.1021/acs.molpharmaceut.5c00602
摘要

13N-NH3 PET imaging provides insights into tumor perfusion and metabolism, hence potentially valuable in oncological diagnosis, staging, and prognosis. However, its in vivo kinetic characteristics and the optimal protocol for kinetic modeling and parametric imaging remain unclear. This study aims to elucidate the kinetic features of 13N-NH3 in lung cancer and its clinical value. Nine lung cancer surgical candidates were prospectively incorporated. Using total-body PET/CT scanner, 35 min 13N-NH3 acquisitions were conducted immediately postinjection. Subsequently, routine 5 min 18F-FDG acquisitions were made. 13N-NH3 PET data were reconstructed into dynamic image series. Tumor lesions and normal organs were segmented using nonthreshold dependent automatic or semiautomatic tools. Reversible and irreversible 2-tissue compartment models (2TC vs 2TiC) using image-derived input functions (IDIFs) with population-based metabolite correction were adopted for parametric modeling. Akaike Information Criterion (AIC) was calculated for model selection. Parametric images were produced with the optimal model for lesions. A total of 9 patients presented with 9 primary lung tumors and 17 histologically confirmed lymphadenopathy. All primary lung tumors and regional lymph node metastases were detectable using both 13N-NH3 and 18F-FDG imaging. Primary lung tumors, regional lymphadenopathy, and lung backgrounds demonstrated smaller AIC using 2TC models with pulmonary artery as IDIF, while other organs favored either 2TC or 2TiC models with the descending aorta as IDIF. Lesion-to-background lung ratios reached around 2.218–3.407 for primary lung tumors and 1.932–2.537 for regional lymphadenopathy 10–20 min postinjection of 13N-NH3. Vt images derived from 2TC modeling showed better lesion-to-background lung ratios (4.511 ± 2.955 for primary tumor, and 2.991 ± 2.152 for regional lymphadenopathy). For 13N-NH3 imaging in lung cancer, a static image can be acquired at 10–20 min postinjection for clinical diagnosis. The reversible 2TC model is preferred over 2TiC, and the Vt image is preferred over other parametric images in terms of lesion contrast.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chen完成签到 ,获得积分10
9秒前
开放的乐驹完成签到 ,获得积分10
22秒前
26秒前
Noob_saibot发布了新的文献求助10
30秒前
SciGPT应助旧同学采纳,获得10
37秒前
Akim应助旧同学采纳,获得10
37秒前
上官若男应助旧同学采纳,获得10
37秒前
Ava应助旧同学采纳,获得10
37秒前
丘比特应助旧同学采纳,获得10
38秒前
大个应助旧同学采纳,获得10
38秒前
wanci应助旧同学采纳,获得10
38秒前
隐形曼青应助旧同学采纳,获得10
38秒前
慕青应助Noob_saibot采纳,获得10
42秒前
haralee完成签到 ,获得积分10
43秒前
deng完成签到 ,获得积分10
52秒前
英俊的铭应助旧同学采纳,获得10
1分钟前
李健应助旧同学采纳,获得10
1分钟前
斯文败类应助旧同学采纳,获得10
1分钟前
Akim应助旧同学采纳,获得10
1分钟前
万能图书馆应助旧同学采纳,获得10
1分钟前
1分钟前
bkagyin应助旧同学采纳,获得10
1分钟前
Sledge应助旧同学采纳,获得30
1分钟前
科研通AI6.2应助旧同学采纳,获得10
1分钟前
烟花应助旧同学采纳,获得10
1分钟前
明亮访梦完成签到,获得积分10
1分钟前
三水完成签到 ,获得积分10
1分钟前
1分钟前
smile完成签到,获得积分10
1分钟前
suge完成签到,获得积分10
1分钟前
navon完成签到,获得积分10
2分钟前
汉堡包应助夏卡卡采纳,获得10
2分钟前
2分钟前
夏卡卡发布了新的文献求助10
2分钟前
充电宝应助科研通管家采纳,获得10
2分钟前
2分钟前
orixero应助科研通管家采纳,获得10
2分钟前
Imran完成签到,获得积分10
2分钟前
大气青枫完成签到,获得积分10
2分钟前
潜行者完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
基于锂离子电池正极材料回收的绿色溶剂开发及工程化应用研究 500
Auslegungsgeschichte 500
Transdermal drug delivery systems market size report 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7640283
求助须知:如何正确求助?哪些是违规求助? 9213304
关于积分的说明 19763492
捐赠科研通 7206317
什么是DOI,文献DOI怎么找? 3276074
关于科研通互助平台的介绍 2437673
邀请新用户注册赠送积分活动 2273518